SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 196.510.0%10:26 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (16764)3/7/1998 11:57:00 PM
From: Hippieslayer  Read Replies (1) of 32384
 
Then what the significance is a more "direct path" to treating a certian disease with a drug or molecule that, in theory, will be less costly to make and easier to administer. Would you say that is correct?

I am familiar with AMGN, the two drug wonder biopharma in Thousand Oaks, Ca. Right up the 405; one of the busiest freeways in America. I believe Neupogen generated roughly 800 million dollars for AMGN last year.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News